Stock listing

ALEC Stock Price, News, Filings & Events — Alector, Inc.

Selected listing: ALEC · BOATS · USD · US

This page tracks Alector, Inc.'s ALEC:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALEC:BOATS. ALEC:BOATS is the stock-level entry point for investors researching Alector, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alector, Inc. is a public company traded under the ticker ALEC in the American market. The company has a market capitalization of approximately $164.3 million. Alector focuses on developing innovative therapies for neurodegenerative diseases.

ALEC:BOATSUSDUSUpdated September 11, 2026
Alector, Inc. logo
Ticker
ALEC:BOATS
Asset type
Stock
Market cap
$238.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Alector, Inc. ALEC:BOATS stock context

This page tracks Alector, Inc.'s ALEC:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALEC:BOATS. ALEC:BOATS is the stock-level entry point for investors researching Alector, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alector, Inc. is a public company traded under the ticker ALEC in the American market. The company has a market capitalization of approximately $164.3 million. Alector focuses on developing innovative therapies for neurodegenerative diseases.

Latest news from Alector, Inc.

All Alector, Inc. news →

Alector, Inc. earnings calls

Research Alector, Inc.

Alternate listings